ATE466880T1 - Cytokinpolypeptidvarianten - Google Patents
CytokinpolypeptidvariantenInfo
- Publication number
- ATE466880T1 ATE466880T1 AT04743175T AT04743175T ATE466880T1 AT E466880 T1 ATE466880 T1 AT E466880T1 AT 04743175 T AT04743175 T AT 04743175T AT 04743175 T AT04743175 T AT 04743175T AT E466880 T1 ATE466880 T1 AT E466880T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- ligand
- native
- cytokine
- terminal
- Prior art date
Links
- 102000004127 Cytokines Human genes 0.000 title abstract 3
- 108090000695 Cytokines Proteins 0.000 title abstract 3
- 239000003446 ligand Substances 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical class 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Error Detection And Correction (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0315182.6A GB0315182D0 (en) | 2003-06-28 | 2003-06-28 | Cytokine variant polypeptides |
| PCT/GB2004/002827 WO2005003165A2 (en) | 2003-06-28 | 2004-06-28 | Cytokine variant polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE466880T1 true ATE466880T1 (de) | 2010-05-15 |
Family
ID=27676290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04743175T ATE466880T1 (de) | 2003-06-28 | 2004-06-28 | Cytokinpolypeptidvarianten |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20070264234A1 (de) |
| EP (1) | EP1639002B1 (de) |
| JP (1) | JP2008504001A (de) |
| AT (1) | ATE466880T1 (de) |
| CA (1) | CA2568859A1 (de) |
| DE (1) | DE602004027039D1 (de) |
| GB (1) | GB0315182D0 (de) |
| WO (1) | WO2005003165A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1771467A2 (de) * | 2004-07-26 | 2007-04-11 | Asterion Limited | Linker |
| GB0606946D0 (en) * | 2006-04-06 | 2006-05-17 | Asterion Ltd | Polypeptide antagonist |
| US9885050B2 (en) * | 2007-11-08 | 2018-02-06 | The University Of Chicago | Molecular affinity clamp technology and uses thereof |
| WO2010024557A2 (en) * | 2008-08-25 | 2010-03-04 | Viromed Co., Ltd. | Biopolymer conjugates comprising an interleukin-11 analog |
| KR101853405B1 (ko) * | 2010-10-20 | 2018-05-02 | 주식회사 티움바이오 | 인자 ｉｘ 활성을 갖는 융합 단백질 |
| US9156897B2 (en) * | 2012-06-08 | 2015-10-13 | Alkermes, Inc. | Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide |
| US11680091B2 (en) | 2018-02-23 | 2023-06-20 | The University Of Chicago | Methods and composition involving thermophilic fibronectin type III (FN3) monobodies |
| MX2023011268A (es) | 2021-03-24 | 2023-12-14 | Alkermes Inc | Anticuerpos upar y proteínas de fusión con estos. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635599A (en) * | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
| DK0851925T3 (da) * | 1995-09-21 | 2005-11-28 | Genentech Inc | Humane Væksthormonvarianter |
| BR9811755A (pt) * | 1997-09-08 | 2000-08-29 | Metabolic Pharmaceutical Ltd | Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica |
| EP1115854A1 (de) * | 1998-09-25 | 2001-07-18 | G.D. Searle & Co. | Methode zur herstellung von permuteinen durch scanning permutagenese |
| AU2003256566A1 (en) * | 2002-07-16 | 2004-02-02 | Stuart Bussell | Methods to construct multimeric dna and polymeric protein sequences as direct fusions or with linkers |
-
2003
- 2003-06-28 GB GBGB0315182.6A patent/GB0315182D0/en not_active Ceased
-
2004
- 2004-06-28 WO PCT/GB2004/002827 patent/WO2005003165A2/en not_active Ceased
- 2004-06-28 JP JP2006518330A patent/JP2008504001A/ja active Pending
- 2004-06-28 EP EP04743175A patent/EP1639002B1/de not_active Expired - Lifetime
- 2004-06-28 US US10/561,831 patent/US20070264234A1/en not_active Abandoned
- 2004-06-28 DE DE602004027039T patent/DE602004027039D1/de not_active Expired - Fee Related
- 2004-06-28 CA CA002568859A patent/CA2568859A1/en not_active Abandoned
- 2004-06-28 AT AT04743175T patent/ATE466880T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008504001A (ja) | 2008-02-14 |
| WO2005003165A3 (en) | 2005-07-14 |
| EP1639002B1 (de) | 2010-05-05 |
| EP1639002A2 (de) | 2006-03-29 |
| CA2568859A1 (en) | 2005-01-13 |
| DE602004027039D1 (de) | 2010-06-17 |
| WO2005003165A2 (en) | 2005-01-13 |
| US20070264234A1 (en) | 2007-11-15 |
| GB0315182D0 (en) | 2003-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1833847T3 (pl) | Polipeptydy fuzyjne IGF-1 oraz ich zastosowanie terapeutyczne | |
| EA200700210A1 (ru) | ВАРИАНТЫ ОБЛАСТИ Fc | |
| IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
| EP2298331A3 (de) | Verwendung von Transthyretinpeptid-/-proteinfusionen zur Erhöhung der Serumshalbwertszeit von pharmakologisch aktiven Peptiden/Proteinen | |
| EP2360180A3 (de) | Motive der bauchspeicheldrüsen-polypeptid familie, polypeptide und methoden und verwendung derselben | |
| WO2003027246A3 (en) | Antagonists | |
| WO2006001023A3 (en) | Chimeric proteins and uses thereof | |
| DE60333306D1 (de) | Modifizierte transferrin-fusionsproteine mit doppelten transferrin-amino- oder carboxy-terminalen domänen | |
| EP1161149A4 (de) | Für angiogene gefässe spezifische ng2/hm proteoglycan-bindende peptide und verwandte methoden | |
| EP2343318A3 (de) | Antikörper die an ein C-terminales Fragment des Apolipoproteins E binden | |
| ATE542920T1 (de) | Modifiziertes menschliches wachstumshormon | |
| BR0212256A (pt) | Proteìnas de fusão de transferrina modificadas | |
| WO2008066583A3 (en) | Cell-free synthesis of proteins containing unnatural amino acids | |
| GEP20115333B (en) | Antagonist antibodies directed against calcitonin generelated peptide and using same | |
| EP2031063A3 (de) | Modulatoren von Duftrezeptoren | |
| CY1112787T1 (el) | Πολλαπλομερη του υποδοχεα κυτοκινης ζcytor17 | |
| WO2004020405A3 (en) | Modified transferrin fusion proteins | |
| EP2949658A3 (de) | Spezifisch an HGF-Rezeptor (cMet) bindende Peptide und deren Verwendung | |
| WO2002002627A3 (en) | Interferon-like protein zcyto21 | |
| EA200600477A1 (ru) | Пептиды и соединения, которые связываются с рецептором | |
| ATE322503T1 (de) | Gefrierschutzprotein | |
| ATE466880T1 (de) | Cytokinpolypeptidvarianten | |
| WO2007047504A3 (en) | Natriuretic peptide modified transferrin fusion proteins | |
| GEP20115196B (en) | Neublastin variants | |
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |